**Core Concept**
Myeloma is a type of plasma cell malignancy characterized by the proliferation of malignant plasma cells in the bone marrow, leading to bone destruction and the release of various tumor products into the bloodstream, including monoclonal immunoglobulins and lytic enzymes.
**Why the Correct Answer is Right**
The patient's presentation of sudden weakness of the legs and urinary retention, along with laboratory findings of anemia (hemoglobin 7.3 gm/dl), hypercalcemia (serum calcium 12.6 mg/dl), and renal impairment (urea 178 mg/dl), is suggestive of a paraneoplastic syndrome associated with multiple myeloma. The high levels of globulin (7.1 gm/dl) and alkaline phosphatase (100 u/I) also point towards a diagnosis of myeloma, which is characterized by the production of large amounts of monoclonal immunoglobulins that can cause renal impairment and hypercalcemia. The presence of lytic lesions in the bones can also lead to the release of calcium into the bloodstream, causing hypercalcemia.
**Why Each Wrong Option is Incorrect**
* **Option A:** This is not a relevant diagnosis in this context, as it does not explain the patient's laboratory findings or clinical presentation.
* **Option B:** This is a possible diagnosis, but it is less likely than myeloma, as it does not fully explain the patient's laboratory findings, particularly the high levels of globulin and alkaline phosphatase.
* **Option C:** This is a possible diagnosis, but it is less likely than myeloma, as it does not explain the patient's laboratory findings, particularly the high levels of globulin and alkaline phosphatase.
**Clinical Pearl / High-Yield Fact**
Myeloma is a malignancy that can cause a wide range of systemic symptoms, including anemia, renal impairment, and hypercalcemia, due to the production of monoclonal immunoglobulins and lytic enzymes by malignant plasma cells.
**Correct Answer:** D.
Free Medical MCQs Β· NEET PG Β· USMLE Β· AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.